Latest news
Summit Therapeutics (SMMT) Launches Global Phase II/III Trial fo - GuruFocusGuruFocus · Wed, 05 Aug 2026 18:29:19 GMTSystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMT